Advertisement New England Biolabs - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More

New England Biolabs


New England Biolabs

The past two decades has seen a dramatic rise in the number of protein-based pharmaceuticals (“biologics”) and companion diagnostics. These important areas of clinical and pharmaceutical science are becoming more reliant than ever on cutting edge molecular biology tools and techniques.

For instance, companion diagnostics based on DNA amplification can foster a better match of effective therapies with the patients they’re most likely to help; personalized medicine utilizing next-generation sequencing can help tailor treatments for specific patient characteristics; and a wide range of biologics is now being developed thanks to recombinant DNA technologies. Additionally, development, manufacturing and quality control of novel biologics and biosimilars involve rigorous characterization of post-translational modifications such as glycosylation.

New England BiolabsAre you ready to make the most of what’s available now – and what’s coming next?

We understand the challenges you face, and we are uniquely structured to help you meet them. At New England Biolabs®, we share your focus on, and passion for, research and discovery. We were founded by scientists (and remain an independent company today) and have published almost 900 peer-reviewed research studies in top scientific journals over the past four decades.

In addition to our reputation as a leading supplier of molecular biology enzymes and other life science consumables, we have a product portfolio that has the potential to touch on almost every stage of today’s drug discovery and development process. We also have deep roots in basic research, as well as experience in drug target identification and the development of new lab-based technologies for diagnostic applications. We were one of the first companies to recognize the promise of recombinant technologies, and we have created solutions that have since been used in the development, manufacturing and quality control of biologics.

Simply put, we’re ready and able to collaborate with pharma and biotech companies, supporting the discoveries that come out of your lab and help move them all the way through clinical testing, manufacturing, quality control and into regulated markets around the world.

New England BiolabsNew England Biolabs, Inc.
240 County Road
Ipswich, MA 01938
Phone 978-9275054
Toll Free (Orders) 1-800-632-5227
Toll Free (Technical Support) 1-800-632-7799
Fax 978-921-1350
For custom inquiries:

Quick Contact New England Biolabs

Top Products from New England Biolabs

Featured Applications

Our breakthroughs and innovations have made New England Biolabs a partner of choice for many leading biotech and pharma companies. Highlights of recent innovations include:

Accelerating Biological Drug ProductionRapid PNGase F completely removes N-glycans from antibodies and fusion proteins in 10 minutes or less, offering the potential to accelerate the quality control analysis of antibody-based therapeutics production. Additionally, we offer a diverse selection of highly-pure recombinant exo-glycosidases that better the structural characterization of glycans on biologics and biosimilars and offer…
Quick Contact New England Biolabs

New England Biolabs® Launches NEBNext Direct™ Technology with Cancer HotSpot Panel

New England Biolabs (NEB®) will announce the launch of the NEBNext Direct Cancer HotSpot Panel at the American Association for...
12th May 2016

NEBNext® Delivers an Improved qPCR-based Library Quantitation Solution

New England Biolabs® (NEB®) announces the release of the NEBNext Library Quant Kit for Illumina®, a qPCR-based solution for accurate...
9th November 2015

NEB® Launches New NEBNext® Ultra™ II Kit for NGS Library Preparation with as Little as 500 pg of Input DNA

New England Biolabs® (NEB) today announced the release of the NEBNext Ultra II DNA Library Prep Kit for Illumina® next...
9th November 2015

New England Biolabs® Announces Plans for GMP Manufacturing

With the goal of better serving its customers in more regulated markets, New England Biolabs (NEB®) today announced plans to...
9th November 2015

New England Biolabs® Expands its NEBNext® Line of Next-Generation Sequencing Reagents with a DNA Repair Solution for FFPE Samples

New England Biolabs (NEB®) announces a novel DNA repair reagent aimed at helping to address the historically intractable challenge of...
9th November 2015
Quick Contact New England Biolabs

Quick Contact New England Biolabs

The NEB Difference

New England Biolabs' (NEB) attention to quality assurance (QA) and quality control (QC) is second to none. After all, its...
9th November 2015
Quick Contact New England Biolabs
Quick Contact New England Biolabs

Contact New England Biolabs

Optional Data

Almost there, complete this form and hit the submit button to complete your registration.


Finally, complete a quick security check and confirm terms and conditions:

Quick Contact New England Biolabs